This article is a Preprint
Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.
Real-World Effectiveness and Safety of Nirmatrelvir-Ritonavir (Paxlovid)-Treated for COVID-19 Patients with Onset of More than Five Days: A Retrospective Cohort Study (preprint)
ssrn; 2024.
Preprint
in English
| PREPRINT-SSRN | ID: ppzbmed-10.2139.ssrn.4718397
Subject(s)
Full text:
Available
Collection:
Preprints
Database:
PREPRINT-SSRN
Main subject:
COVID-19
Language:
English
Year:
2024
Document Type:
Preprint
Similar
MEDLINE
...
LILACS
LIS